Guest Editor’s Note: 20th Anniversary Special Section on Medical Communications Rebecca Vermeulen Medical Communications 01 November 2009 Pages: 635 - 636
Surveying Medical Information Across Europe: The Present and the Future Sharon LeigbtonJanet E. Davies Medical Communications 01 November 2009 Pages: 637 - 654
Auditing Medical Information Services Across Western Europe: A Cost-Effective Approach Charlotte WormleightonSharon Leighton Medical Communications 01 November 2009 Pages: 655 - 662
A Practical Approach to Evidence-Based Medicine for the Medical Communications Professional Patrick J. BryantMichael J. SteinbergChristopher M. Marrone Medical Communications 01 November 2009 Pages: 663 - 672
The Changing Roles of Medical Communications Professionals: Evolution of the Core Curriculum Alicia Alexander CodoganStacey M. Fung Medical Communications 01 November 2009 Pages: 673 - 684
Surveys of Medical Liaison Practices Across the Pharmaceutical Industry: A Review J. Lynn BassChristopher M. MarroneCraig Klinger Medical Communications 01 November 2009 Pages: 685 - 695
Results of a Qualitative Market Research Study Evaluating the Quality of Medical Letters Radeguade FettKai BrunsSabine Lischka-Wittmann Medical Communications 01 November 2009 Pages: 697 - 703
Historical Perspective of Technologies Used in Medical Communications, Past, Present, and Future Lesley FierroDonna SavulichChristina Wyble Medical Communications 01 November 2009 Pages: 705 - 712
Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 1. The Process Parvin FardipourGary LittmanMichael Krams Statistics 01 November 2009 Pages: 713 - 723
Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies Parvin FardipourGary LittmanMichael Krams Statistics 01 November 2009 Pages: 725 - 734
Evaluating REMS Tools: Issues in Survey Design Louis A. Morris Drug Safety 01 November 2009 Pages: 735 - 747
A Matrix to Determine Health Economic Viability Throughout Product Development: A Pharmaceutical Industry Perspective Michiel HemelsMichael WoldenThomas R. Pharmacoeconomics 01 November 2009 Pages: 749 - 756
The Current Situation of Oncology Drug Lag in Japan and Strategic Approaches for Pharmaceutical Companies Junichi HashimotoEiji UedaMamoru Narukawa Pharmacoeconomics 01 November 2009 Pages: 757 - 765
